Efficacy and Safety of Infliximab in HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy

PURPOSE: To determine the efficacy and safety of infliximab therapy in patients with HLA B-27-associated ocular inflammation resistant or intolerant to conventional immunomodulatory therapy. METHODS: This was a retrospective observational case series. All cases were uveitic patients with positive HL...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajwa, Asima, Maleki, Arash, Payal, Abhishek R, Fandiño, Adriana, Padrón, María Inés Menéndez, Walsh, Marisa, Foster, C Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PUBLISHED BY KNOWLEDGE E 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591838/
https://www.ncbi.nlm.nih.gov/pubmed/33133436
http://dx.doi.org/10.18502/jovr.v15i4.7786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591838/
https://www.ncbi.nlm.nih.gov/pubmed/33133436
http://dx.doi.org/10.18502/jovr.v15i4.7786

Ejemplares similares